NanoVation Therapeutics
Vancouver, CA · 1 known investors
NanoVation Therapeutics develops lipid nanoparticle (LNP) and mRNA delivery technologies for gene therapies, supporting drug development partners across mRNA synthesis, LNP formulation, and preclinical delivery optimization. It works with pharmaceutical and biotech partners on end-to-end gene therapy delivery.
Founders & leadership
PC
Pieter Cullis
DW
Dominik Witzigmann
JK
Jayesh Kulkarni
ZJ
Zach Jonasson
DM
David Main
Investors · 1
Frequently asked questions
- What does NanoVation Therapeutics do?
- NanoVation Therapeutics develops lipid nanoparticle (LNP) and mRNA delivery technologies for gene therapies, supporting drug development partners across mRNA synthesis, LNP formulation, and preclinical delivery optimization. It works with pharmaceutical and biotech partners on end-to-end gene therapy delivery.
- Who founded NanoVation Therapeutics?
- NanoVation Therapeutics was founded by Pieter Cullis, Dominik Witzigmann, Jayesh Kulkarni, Zach Jonasson, David Main.
- Who are NanoVation Therapeutics's investors?
- NanoVation Therapeutics's investors include Innovation UBC.
- Where is NanoVation Therapeutics headquartered?
- NanoVation Therapeutics is headquartered in Vancouver, CA.